Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Cash from Operations: 2020-2025

Historic Cash from Operations for Incannex Healthcare (IXHL) over the last 6 years, with Jun 2025 value amounting to -$12.5 million.

  • Incannex Healthcare's Cash from Operations fell 309.80% to -$9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.5 million, marking a year-over-year decrease of 57.75%. This contributed to the annual value of -$12.5 million for FY2025, which is 21.03% up from last year.
  • As of FY2025, Incannex Healthcare's Cash from Operations stood at -$12.5 million, which was up 21.03% from -$15.8 million recorded in FY2024.
  • In the past 5 years, Incannex Healthcare's Cash from Operations ranged from a high of $12.8 million in FY2022 and a low of -$15.8 million during FY2024.
  • For the 3-year period, Incannex Healthcare's Cash from Operations averaged around -$13.0 million, with its median value being -$12.5 million (2025).
  • Per our database at Business Quant, Incannex Healthcare's Cash from Operations soared by 285.35% in 2022 and then plummeted by 183.93% in 2023.
  • Over the past 5 years, Incannex Healthcare's Cash from Operations (MRY) stood at -$5.2 million in 2021, then soared by 346.61% to $12.8 million in 2022, then plummeted by 183.93% to -$10.7 million in 2023, then plummeted by 47.41% to -$15.8 million in 2024, then rose by 21.03% to -$12.5 million in 2025.
  • Its Cash from Operations stands at -$12.5 million for FY2025, versus -$15.8 million for FY2024 and -$10.7 million for FY2023.